Divi's Laboratories Limited (NSE:DIVISLAB)
India · Delayed Price · Currency is INR 9,030.00
+7.00 (0.08%)
Oct 15, 2026, 3:28 PM IST
Divi's Laboratories Market Cap
Divi's Laboratories has a market cap or net worth of 2.4 trillion as of October 15, 2026. It is the 978th most valuable company in the world and the 35th biggest in India. Its market cap has increased by 37.63% in one year.
Market Cap
2.40T
Enterprise Value
2.36T
Revenue
112.30B
Global Rank
Country Rank
#35 India
PE Ratio
81.93
ChartMarket Cap Chart
Since March 12, 2003, Divi's Laboratories's market cap has increased from 2.04B to 2.40T, an increase of 117,667.74%. That is a compound annual growth rate of 34.92%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 15, 2026 | 2.40T | 41.26% |
| Dec 31, 2025 | 1.70T | 4.82% |
| Dec 31, 2024 | 1.62T | 56.22% |
| Dec 29, 2023 | 1.04T | 14.38% |
| Dec 30, 2022 | 906.10B | -27.04% |
| Dec 31, 2021 | 1.24T | 21.77% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.22T |
| Zydus Lifesciences | 1.13T |
| Laurus Labs | 1.12T |
| Cipla | 1.06T |
| Mankind Pharma | 991.19B |
| Aurobindo Pharma | 982.11B |
| Glenmark Pharmaceuticals | 644.26B |
| Alkem Laboratories | 622.34B |